Page 91 - AN-1-1

Advanced Neurology TRPM2 in neurological disorders

Microcirculation, 15(4): 359–371. 46. Xicoy H, Wieringa B, Martens GJ, 2017, The SH-SY5Y cell
line in Parkinson’s disease research: A systematic review.
https://doi.org/10.1080/10739680701762656
Mol Neurodegener, 12(1): 10.
35. Sumoza-Toledo A, Lange I, Cortado H, et al., 2011, Dendritic
cell maturation and chemotaxis is regulated by TRPM2- https://doi.org/10.1186/s13024-017-0149-0
2+
mediated Lysosomal Ca release. FASEB J, 25(10): 3529–3542. 47. Yıldızhan K, Nazıroğlu M, 2021, Protective role of selenium
on MPP+ and homocysteine-induced TRPM2 channel
https://doi.org/10.1096/fj.10-178483
activation in SH-SY5Y cells. J Recept Signal Transduct Res,
36. DeMaagd G, Philip A, 2015, Parkinson’s disease and online ahead of print.
its management: Part 1: Disease entity, risk factors,
pathophysiology, clinical presentation, and diagnosis. P T, https://doi.org/10.1080/10799893.2021.1981381
40(8): 504–532. 48. An X, Fu Z, Mai C, et al., 2019, Increasing the TRPM2
channel expression in human neuroblastoma SH-SY5Y cells
37. Kin K, Yasuhara T, Kameda M, et al., 2019, Animal models
for Parkinson’s disease research: Trends in the 2000s. Int J augments the susceptibility to ROS-induced cell death. Cells,
Mol Sci, 20(21): 5402. 8(1): 1–8.
https://doi.org/10.3390/cells8010028
https://doi.org/10.3390/ijms20215402
49. Vaidya B, Sharma SS, 2020, Transient receptor potential
38. Sun Y, Sukumaran P, Selvaraj S, et al., 2018, TRPM2
Promotes neurotoxin MPP+/MPTP-induced cell death. Mol channels as an emerging target for the treatment of
Neurobiol, 55(1): 409–420. Parkinson’s disease: An insight into role of pharmacological
interventions. Front Cell Dev Biol, 8: 584513.
https://doi.org/10.1007/s12035-016-0338-9
https://doi.org/10.3389/fcell.2020.584513
39. Meredith GE, Rademacher DJ, 2011, MPTP mouse models of
Parkinson’s disease: An update. J Parkinsons Dis, 1(1): 19–33. 50. Ding XM, Zhao LJ, Qiao HY, et al., 2019, Long Non-coding
RNA-p21 regulates MPP+-induced neuronal injury by
https://doi.org/10.3233/JPD-2011-11023 targeting miR-625 and depressing TRPM2 in SH-SY5Y cells.
40. Malko P, Mortadza SA, McWilliam J, et al., 2019, TRPM2 Chem Biol Interact, 307: 73–81.
channel in microglia as a new player in neuroinflammation https://doi.org/10.1016/j.cbi.2019.04.017
associated with a spectrum of central nervous system
pathologies. Front Pharmacol, 10: 239. 51. Manoharan S, Guillemin GJ, Abiramasundari RS, et al.,
2016, The role of reactive oxygen species in the pathogenesis
https://doi.org/10.3389/fphar.2019.00239 of Alzheimer’s disease, Parkinson’s disease, and Huntington’s
41. Hermosura MC, Garruto RM, 2007, TRPM7 and TRPM2- disease: A mini review. Oxid Med Cell Longev, 2016: 8590578.
candidate susceptibility genes for Western Pacific ALS and https://doi.org/10.1155/2016/8590578
PD? Biochim Biophys Acta, 1772(8): 822–835.
52. Drummond E, Wisniewski T, 2017, Alzheimer’s disease:
https://doi.org/10.1016/j.bbadis.2007.02.008 Experimental models and reality. Acta Neuropathol, 133(2):
42. Hermosura MC, Cui AM, Go RC, et al., Altered functional 155–175.
properties of a TRPM2 variant in guamanian ALS and PD. https://doi.org/10.1007/s00401-016-1662-x
Proc Natl Acad Sci U S A, 105(46): 18029–18034.
53. Chishti MA, Yang DS, Janus C, et al., 2001, Early-onset
https://doi.org/10.1073/pnas.0808218105 amyloid deposition and cognitive deficits in transgenic
43. Vaidya B, Kaur H, Thapak P, et al., 2022, Pharmacological mice expressing a double mutant form of amyloid precursor
modulation of TRPM2 channels via PARP pathway leads to protein 695. J Biol Chem, 276(24): 21562–21570.
neuroprotection in MPTP-induced Parkinson’s disease in https://doi.org/10.1074/jbc.M100710200
Sprague dawley rats. Mol Neurobiol, 59(3): 1528-1542.
54. Radde R, Bolmont T, Kaeser SA, et al., 2006, Abeta42-driven
44. Yu Y, Xie A, Yang S, 2014, TrkA pathway(s) are involves cerebral amyloidosis in transgenic mice reveals early and
in the regulation of TRPM2 and TRPM7 expression in robust pathology. EMBO Rep, 7(9): 940–946.
the substantia Nigra of the Parkinson’s disease rat model
induced by 6-hydroxydopamine. Adv Res, 2: 782–796. https://doi.org/10.1038/sj.embor.7400784
55. Lewis J, McGowan E, Rockwood J, et al., 2000, Neurofibrillary
45. Nazıroğlu M, Özgül C, Çelik O, et al., 2011,
Aminoethoxydiphenyl borate and flufenamic acid inhibit tangles, amyotrophy and progressive motor disturbance in
2+
Ca influx through TRPM2 channels in rat dorsal root mice expressing mutant (P301L) tau protein. Nat Genet,
ganglion neurons activated by ADP-ribose and rotenone. 25(4): 402–405.
J Membr Biol, 241(2): 69–75. https://doi.org/10.1038/78078
https://doi.org/10.1007/s00232-011-9363-9 56. Lewis J, Dickson DW, Lin WL, et al., 2001, Enhanced

Volume 1 Issue 1 (2022) 14 https://doi.org/10.36922/an.v1i1.3